HSPC Archives - Maxcyte

Genome-Wide Analysis of Off-Target CRISPR/Cas9 Activity in Single-Cell-Derived Human Hematopoietic Stem and Progenitor Cell Clones
Gallery
Genome-Wide Analysis of Off-Target CRISPR/Cas9 Activity in Single-Cell-Derived Human Hematopoietic Stem and Progenitor Cell Clones

Genome-Wide Analysis of Off-Target CRISPR/Cas9 Activity in Single-Cell-Derived Human Hematopoietic Stem and Progenitor Cell Clones

St Jones2021-06-25T17:05:46+00:00November 11th, 2020|Comments Off

Boosting the Efficacy of Tumor Infiltrating Lymphocytes via PD-1 Gene Editing
Gallery
Boosting the Efficacy of Tumor Infiltrating Lymphocytes via PD-1 Gene Editing

Boosting the Efficacy of Tumor Infiltrating Lymphocytes via PD-1 Gene Editing

ali2020-07-07T16:10:30+00:00May 16th, 2020|0 Comments

CRISPR-mediated Mutation Correction of Hematopoietic Stem Cells from Patients with X-linked Chronic Granulomatous Disease Using Non-Viral Cell Engineering
Gallery
CRISPR-mediated Mutation Correction of Hematopoietic Stem Cells from Patients with X-linked Chronic Granulomatous Disease Using Non-Viral Cell Engineering

CRISPR-mediated Mutation Correction of Hematopoietic Stem Cells from Patients with X-linked Chronic Granulomatous Disease Using Non-Viral Cell Engineering

ali2020-07-07T16:05:23+00:00May 16th, 2020|Comments Off

Achieving Therapeutic Efficacy with a High Performance, Electroporation-based Cellular Engineering Technology
Gallery
Achieving Therapeutic Efficacy with a High Performance, Electroporation-based Cellular Engineering Technology

Achieving Therapeutic Efficacy with a High Performance, Electroporation-based Cellular Engineering Technology

ali2021-07-28T16:20:04+00:00May 16th, 2020|0 Comments

Accelerating Discovery and Development: Reducing Risk with High Performance Transfection of the Right Cell for the Right Application
Gallery
Accelerating Discovery and Development: Reducing Risk with High Performance Transfection of the Right Cell for the Right Application

Accelerating Discovery and Development: Reducing Risk with High Performance Transfection of the Right Cell for the Right Application

ali2020-07-07T16:12:02+00:00May 16th, 2020|0 Comments

Translation of NK Cell CAR Therapy to the Clinic: Critical Role of Performance & Clinical-scalability
Gallery
Translation of NK Cell CAR Therapy to the Clinic: Critical Role of Performance & Clinical-scalability

Translation of NK Cell CAR Therapy to the Clinic: Critical Role of Performance & Clinical-scalability

ali2020-07-07T16:18:24+00:00May 16th, 2020|0 Comments

Advancing a CCR5 Gene Editing Therapy to Clinical Trial: Overcoming Viral Vector Toxicity
Gallery
Advancing a CCR5 Gene Editing Therapy to Clinical Trial: Overcoming Viral Vector Toxicity

Advancing a CCR5 Gene Editing Therapy to Clinical Trial: Overcoming Viral Vector Toxicity

ali2020-07-07T16:38:20+00:00May 15th, 2020|Comments Off

Engineering NK Cells with High-Affinity CD16 for Enhanced Combination Therapy to Treat B-Cell Lymphoma
Gallery
Engineering NK Cells with High-Affinity CD16 for Enhanced Combination Therapy to Treat B-Cell Lymphoma

Engineering NK Cells with High-Affinity CD16 for Enhanced Combination Therapy to Treat B-Cell Lymphoma

ali2020-07-07T16:03:07+00:00May 15th, 2020|0 Comments

CRISPR-mediated Gene Editing Using a cGMP-Compliant Non-viral Cell Engineering: From iPSC Disease Modeling to Clinically-Meaningful Correction of Monogenic Disease Mutations in Patient Cells
Gallery
CRISPR-mediated Gene Editing Using a cGMP-Compliant Non-viral Cell Engineering: From iPSC Disease Modeling to Clinically-Meaningful Correction of Monogenic Disease Mutations in Patient Cells

CRISPR-mediated Gene Editing Using a cGMP-Compliant Non-viral Cell Engineering: From iPSC Disease Modeling to Clinically-Meaningful Correction of Monogenic Disease Mutations in Patient Cells

ali2020-07-10T15:47:11+00:00May 12th, 2020|Comments Off

Gene Editing: Paving the Way for Accelerated Clinical Development of Adoptive Cell Immunotherapies
Gallery
Gene Editing: Paving the Way for Accelerated Clinical Development of Adoptive Cell Immunotherapies

Gene Editing: Paving the Way for Accelerated Clinical Development of Adoptive Cell Immunotherapies

ali2020-07-10T16:04:55+00:00May 12th, 2020|Comments Off

Web Analytics Made Easy -
StatCounter